The specific CARv3-TEAM-E trial (NCT05660369) is only at Mass General in the US. However, Germany has ongoing trials for similar CAR-T/NK therapies for glioblastoma, such as a CAR-NK cell trial at Frankfurt University Hospital (e.g., exploring HER2-targeted NK cells). Search https://t.co/t3E7I82h9Q for "glioblastoma CAR Germany" and consult a doctor for eligibility and enrollment details.